In this retrospective study using claims data from the OptumLabs Data Warehouse including 24 658 769 eligible person-years of coverage in the USA, there was substantial decline in codeine dispensing between 2010 and 2019. However, we also observed a persistence of codeine prescribing despite the FDA contraindication in 2018. In 2019, codeine was still being prescribed to children aged 12-17 years at 934 prescriptions per 100 000 person-years of coverage and 106 per 100 000 person-years of coverage in children aged<12 years.
|Original language||English (US)|
|Journal||BMJ Paediatrics Open|
|State||Published - Dec 1 2021|
- health services research
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health